| 序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
| 1 |
873551-53-2 |
FTIDC |
≥98% |
|
询价 |
| 2 |
864864-17-5 |
CFMTI |
≥98% |
|
询价 |
| 3 |
832714-46-2 |
APD 668 |
≥98% |
|
询价 |
| 4 |
783331-24-8 |
MRK-016 |
≥98% |
|
询价 |
| 5 |
74550-97-3 |
Bimolane |
≥98% |
|
询价 |
| 6 |
1644158-57-5 |
ARN14974 |
≥98% |
|
询价 |
| 7 |
1456858-58-4 |
HG-9-91-01 |
≥98% |
|
询价 |
| 8 |
1185329-96-7 |
IXA-4 |
≥98% |
|
询价 |
| 9 |
1144035-53-9 |
PF-8380 |
≥98% |
|
询价 |
| 10 |
1286725-49-2 |
VU0529331 |
≥98% |
|
询价 |
| 11 |
630124-46-8 |
AST487(NVP-AST487) |
≥98% |
|
询价 |
| 12 |
104821-25-2 |
Dihydroethidium |
≥98% |
|
询价 |
| 13 |
736994-63-1 |
Cyantraniliprole |
≥98% |
|
询价 |
| 14 |
934828-12-3 |
HDAC-IN-4(CXD-101 AZD-9468) |
≥98% |
|
询价 |
| 15 |
|
Clemizole hydrochloride |
≥98% |
|
询价 |
| 16 |
1477949-42-0 |
CAY10683(Santacruzamate A) |
≥98% |
|
询价 |
| 17 |
407587-33-1 |
CaCCinh-A01 |
≥98% |
|
询价 |
| 18 |
1225037-39-7 |
Bimiralisib(PQR309) |
≥98% |
|
询价 |
| 19 |
836683-15-9 |
Acumapimod(BCT-197) |
≥98% |
|
询价 |
| 20 |
1197300-24-5 |
TGR5 Receptor Agonist |
≥98% |
|
询价 |
| 21 |
372523-75-6 |
TCS-OX2-29 |
≥98% |
|
询价 |
| 22 |
174634-09-4 |
TAS-103 dihydrochloride |
≥98% |
|
询价 |
| 23 |
612530-44-6 |
PTP1B-IN-1 |
≥98% |
|
询价 |
| 24 |
1991986-30-1 |
ML364 |
≥98% |
|
询价 |
| 25 |
1186426-66-3 |
DBPR108 |
≥98% |
|
询价 |
| 26 |
402567-16-2 |
Firategrast(SB-683699) |
≥98% |
|
询价 |
| 27 |
223488-57-1 |
Evatanepag(CP-533536) |
≥98% |
|
询价 |
| 28 |
1462249-75-7 |
PFK-158 |
≥98% |
|
询价 |
| 29 |
784210-88-4 |
RGB-286638 free base |
≥98% |
|
询价 |
| 30 |
591778-70-0 |
CP640186 HCl |
≥98% |
|
询价 |
| 31 |
1446502-11-9 |
Enasidenib(AG-221) |
≥98% |
|
询价 |
| 32 |
916170-19-9 |
AC 55541 |
≥98% |
|
询价 |
| 33 |
1783816-74-9 |
NVS-PAK1-1 |
≥98% |
|
询价 |
| 34 |
664993-53-7 |
JW 55 |
≥98% |
|
询价 |
| 35 |
119431-25-3 |
Eliprodil |
≥98% |
|
询价 |
| 36 |
338-95-4 |
Isoflupredone |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 37 |
189188-38-3 |
Doripenem Impurity MAP-alfa isomer(Meropenem Related Compound 1) |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 38 |
651734-12-2 |
20-Hydroxyvitamin D3(20-OH-D3) |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 39 |
|
ABI-231-10bb |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 40 |
1253697-93-6 |
ABI-274 |
≥98% |
|
询价 |
| 41 |
153415-46-4 |
Taxcultine |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 42 |
14685-79-1 |
Fludeoxyglucose Related Compound B |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 43 |
1471-56-3 |
Decarboxamide meprobamate |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 44 |
2413185-88-1 |
Oseltamivir Impurity 17 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 45 |
2204245-48-5 |
Bamocaftor(VX-659) |
≥98% |
|
询价 |
| 46 |
26993-30-6 |
Sphingosine-1-phosphate(S1P) |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 47 |
|
Avibactam sodium hydrate(NXL 104 hydrate) |
≥98% |
|
询价 |
| 48 |
76812-49-2 |
Acemetacin Impurity F |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 49 |
67232-80-8 |
DMPG |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 50 |
2230200-09-4 |
GLP-1 receptor agonist 3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 51 |
2382719-60-8 |
TT-OAD2 |
≥98% |
|
询价 |
| 52 |
147083-36-1 |
Alcaftadine Impuity 3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 53 |
27625-86-1 |
Blepharin |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 54 |
1212-53-9 |
Z-Gly-Ome |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 55 |
5891-45-2 |
Z-Glu-OtBu |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 56 |
5672-83-3 |
Z-Glu-OMe |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 57 |
1155-62-0 |
Z-Glu-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 58 |
|
Z-Glu(OtBu)-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 59 |
2650-64-8 |
Z-Gln-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 60 |
132388-60-4 |
Z-Gln(Trt)-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
m.cnreagent.com
